Highlights
1 patentProfile claimed by owner
About
Improved Versions of Existing Drugs and Cannabis Delivery
BioNanoSim (BNS) has developed a proprietary technology platform for the nano-encapsulation of drugs to improve delivery profile and therapeutic performance. Research conducted by Professor Simon Benita and his team has demonstrated the potential of BNS's nano-encapsulation technology to design innovative routes of administration across a range of therapeutic areas including oncology, ophthalmology, and metabolic diseases. In addition, BNS is using its nano-encapsulation technologies to develop topical and ocular cannabis-based products.
Identity
| Name | BioNanoSim |
|---|---|
| Slug | bionanosim |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMbet7EIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Hadassah Ein Kerem, Jerusalem, Israel |
Web & social
| Website | https://www.bionanosim.com/ |
|---|---|
| https://www.linkedin.com/company/77224750 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical Cannabis
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
pharma-companiescancerpharmaceuticalsnanotechnologydrug-deliveryhealthcare-providerscannabistreatmentsbioconvergence
Funding
| Total raised | $6.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}